Sultana Marcia Zalalee

Array ( [id] => 3619808 [patent_doc_number] => 05612040 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-18 [patent_title] => 'Non-infectious foot-and-mouth disease viruses' [patent_app_type] => 1 [patent_app_number] => 8/418716 [patent_app_country] => US [patent_app_date] => 1995-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4868 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/612/05612040.pdf [firstpage_image] =>[orig_patent_app_number] => 418716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4297804 [patent_doc_number] => 06187320 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Equine herpesviruses (EHV) which contain foreign DNA, process for the preparation thereof and the use thereof in vaccines' [patent_app_type] => 1 [patent_app_number] => 8/416544 [patent_app_country] => US [patent_app_date] => 1995-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 13402 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187320.pdf [firstpage_image] =>[orig_patent_app_number] => 416544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3973593 [patent_doc_number] => 05916754 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-29 [patent_title] => 'Bayou hantavirus and related methods' [patent_app_type] => 1 [patent_app_number] => 8/390888 [patent_app_country] => US [patent_app_date] => 1995-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15684 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/916/05916754.pdf [firstpage_image] =>[orig_patent_app_number] => 390888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3991625 [patent_doc_number] => 05922327 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Equine herpes virus glycoproteins' [patent_app_type] => 1 [patent_app_number] => 8/338530 [patent_app_country] => US [patent_app_date] => 1995-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 23 [patent_no_of_words] => 15567 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922327.pdf [firstpage_image] =>[orig_patent_app_number] => 338530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3843030 [patent_doc_number] => 05766602 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Recombinant packaging defective Sindbis virus vaccines' [patent_app_type] => 1 [patent_app_number] => 8/375235 [patent_app_country] => US [patent_app_date] => 1995-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14383 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/766/05766602.pdf [firstpage_image] =>[orig_patent_app_number] => 375235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4105787 [patent_doc_number] => 06022726 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Genetically engineered attenuated viruses' [patent_app_type] => 1 [patent_app_number] => 8/318794 [patent_app_country] => US [patent_app_date] => 1994-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 14378 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022726.pdf [firstpage_image] =>[orig_patent_app_number] => 318794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4041418 [patent_doc_number] => 05874280 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Vector vaccines of bovine herpesvirus I' [patent_app_type] => 1 [patent_app_number] => 8/344833 [patent_app_country] => US [patent_app_date] => 1994-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 8405 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874280.pdf [firstpage_image] =>[orig_patent_app_number] => 344833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3883731 [patent_doc_number] => 05833995 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'Use of bluetongue virus proteins as vaccine components' [patent_app_type] => 1 [patent_app_number] => 8/291915 [patent_app_country] => US [patent_app_date] => 1994-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 21 [patent_no_of_words] => 8285 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/833/05833995.pdf [firstpage_image] =>[orig_patent_app_number] => 291915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1602474 [patent_doc_number] => 06432653 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Device and process for cell capture and recovery' [patent_app_type] => B1 [patent_app_number] => 08/291335 [patent_app_country] => US [patent_app_date] => 1994-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 11289 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/432/06432653.pdf [firstpage_image] =>[orig_patent_app_number] => 08291335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4317643 [patent_doc_number] => 06248562 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Chimeric proteins comprising borrelia polypeptides and uses therefor' [patent_app_type] => 1 [patent_app_number] => 8/235836 [patent_app_country] => US [patent_app_date] => 1994-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 135 [patent_figures_cnt] => 137 [patent_no_of_words] => 74568 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248562.pdf [firstpage_image] =>[orig_patent_app_number] => 235836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3808659 [patent_doc_number] => 05788970 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon' [patent_app_type] => 1 [patent_app_number] => 8/219262 [patent_app_country] => US [patent_app_date] => 1994-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 8 [patent_no_of_words] => 10946 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/788/05788970.pdf [firstpage_image] =>[orig_patent_app_number] => 219262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4209491 [patent_doc_number] => 06110466 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Modified plant viruses as vectors' [patent_app_type] => 1 [patent_app_number] => 8/137032 [patent_app_country] => US [patent_app_date] => 1993-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 12427 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110466.pdf [firstpage_image] =>[orig_patent_app_number] => 137032 [rel_patent_id] =>[rel_patent_doc_number] =>)